Today, CDC recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborn from severe RSV illness. RSV is the leading cause of hospitalization for U.S. infants...

Fiftieth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:00 Global Health Cast website: 02:30 Intelligence and timing of COVID boosters 06:30 Legionellosis...

Hepatitis B virus (HBV) infection remains a significant global health concern, with nearly 300 million individuals chronically infected worldwide. To combat this public health challenge, the World Health...

A new paper in Biology Methods and Protocols, published by Oxford University Press, indicates that researchers studying SARS-CoV-2 may have developed new methods to administer vaccines orally, which would be...

Forty-ninth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:15 Acute Respiratory Infection (ARI) incidence and climate factors 04:15 Biological explanation...

A small number of HIV-infected cells remain in the tissues of people living with the virus and who are undergoing antiretroviral therapy. These viral reservoirs, real obstacles to the cure of HIV, have long...

Part 3 of the series on COVID-19 presented by Prof. Bruno Lina, Prof. Catherine Weil-Olivier, and Prof. Joe Schmitt. 00:00 Introduction 02:15 Currently circulating SARS-CoV-2 variants globally 03:20 The...

There is something we can all do to prevent the common cold virus RSV from spreading: disinfecting hands and surfaces as well as gargling with mouthwash when symptoms occur. Every year, respiratory syncytial...

In a recent study published in Human Vaccines & Immunotherapeutics, a group of researchers assessed Chat Generative Pre-trained Transformer (GPT)’s ability to address the 50 most common...

Forty-eighth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:00 Blood biomarkers predicted cognition 6 and 12 months post COVID 03:00 MERS-CoV cases 05:00...

Forty-seventh Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:00 COVID Omicron death risk compared to flu 03:00 Polio emergency 06:00 Respiratory syncytial...

Getting the COVID-19 mRNA vaccine or booster during pregnancy can be beneficial for pregnant women and their babies, a new study found. The study found that the vaccine given to the mother did transfer to the...

The FDA has approved the first vaccine for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD as a result of respiratory syncytial virus (RSV) in infants, from birth...

Herpes viruses lie dormant in the body and can be reactivated by certain circumstances. The herpes virus HCMV is particularly widespread, yet despite its impact, well-tolerated and effective antiviral drugs or...

Part 2 of the series on COVID-19 presented by Prof. Schmitt, Prof. Weil-Olivier, and Prof. Altmann. 00:00 Introduction 02:20 How common is long COVID 03:25 Is long COVID a major public health problem 04:52...

Scientists from Australia and the USA have developed a lymph node-targeted multi-epitope subunit vaccine that induces strong humoral and cellular immune responses against Epstein-Barr virus (EBV) in mice. The...

COVID-19 vaccines are effective against severe cases of the disease in children and adolescents, according to a review. However, with most children now having caught the SARS-CoV-2 virus and building up a...

Forty-sixth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:54 EG.5 variant 02:34 What to do when you catch COVID-19 05:58 Unusual dengue surge in Bangladesh...

Antibodies generated by vaccination are able to cross the placenta and help shield newborns in the vulnerable first months of their lives. Both mother and child benefit when pregnant women are given a COVID-19...

The new variant is a reminder that COVID-19 still poses a risk to public health. The latest COVID-19 variant to make headlines, EG.5, is now the most prevalent variant in the U.S.—accounting for more than 17%...

Forty-fifth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:52 COVID-19 cases update 03:37 How long do COVID-19 symptoms last 05:34 Who should take Paxlovid...

Researchers have developed a groundbreaking vaccine that generates two types of immunity against the Epstein-Barr virus, a virus that almost all of us carry and which has been found to be a primary cause of...

Even among groups with entrenched attitudes to vaccination, GW researchers showed that an empathetic social media approach and constructive information sharing can foster change. Amid ongoing public scrutiny...

Researchers from Michigan State University and the University of British Columbia have invented a system that can quickly and inexpensively detect airborne viruses using the same technology that enables high...

Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine. This is shown by a study from the University of Gothenburg on patients having...

Nine out of 10 U.S. academic scientists surveyed believe scientists have a part to play in reducing vaccine hesitancy among the public, a research team from Arizona State University’s Center for Science...

Part 1 of the series on COVID-19 presented by Prof. Schmitt, Prof. Weil-Olivier, and Dr. Karafillakis. 00:00 Introduction 01:46 Attitude changes to COVID-19 during the pandemic 09:46 Is there an inverse...

Scientists at Washington University in St. Louis have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and...

Artificial intelligence is a new addition to the infectious disease researcher’s toolbox. Yet in merely half a decade, AI has accelerated progress on some of the most urgent issues in medical science and...

Forty-fourth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:35 Dengue epidemiology 01:00 Transmission between mosquitoes and humans 01:58 Dengue risk by...

International scientists have evaluated molecular mechanisms responsible for heterogeneous responses to influenza vaccination among older adults. They have identified potential immunological mediators that...

Forty-third Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:35 Dengue phases 01:30 Clinical signs of dengue fever 02:25 Antibody disease enhancement 03:05...

How do you design a vaccine against a virus not yet known to man? Doing so could help arm us against future pandemics, by rapidly compressing the time it takes to develop protective vaccines. Most vaccines...

Forty-second Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:35 Dengue definition 02:18 Dengue history 03:55 Flavivirus 05:00 Global distribution of...

The global team behind the research, published in Nature Nanotechnology, developed a way to direct the assembly of virus capsids – the protein shell of viruses – at physiological conditions in a precise and...

Post-acute sequelae of COVID-19, also known as post-COVID-19 conditions or long COVID, are a growing cause for concern. Beating COVID-19 is unfortunately no longer limited to surviving the infection, as...

The European Medicines Agency (EMA) has created a concept paper that addresses the need to establish a guideline on the quality aspects of messenger RNA (mRNA) vaccines, emphasizing the number of clinical...

When activated, a protein found in cells that line the body’s tissues can inhibit viral spread — offering the potential for a new defense against COVID-19. Vaccines that spur the creation of antibodies...

Forty-first Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:45 Topics covered 01:17 Global COVID-19 overview 07:01 Blood grouping and SARS-CoV-2 11:22 Most...

After a successful kick-off meeting in November 2022, the AIB had its first technical meeting entitled: Assessing the health burden of vaccine-preventable infections in European Adults: challenges and...

Researchers from Weill Cornell Medicine, Cornell’s Ithaca campus, Singapore University of Technology and Design, and San Jose State University in California have developed a model for optimizing the dispensing...

Part 3 of the Global Health Cast on Dengue presented by Prof. Schmitt and Prof. Schwarz. 00:00 Introduction 02:10 TAK-003 05:35 Study sites for vaccine trials (TIDES) 06:45 Study endpoint design 12:55 Long...

From the early days of the pandemic, it has been evident that a COVID-19 infection in pregnancy can be serious. Hundreds of studies from around the world have consistently shown that a COVID-19 infection in...

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 600 million confirmed cases and 6.5 million deaths worldwide. mRNA-based vaccines have...

U.S. intelligence agencies found no direct evidence that the COVID-19 pandemic stemmed from an incident at China’s Wuhan Institute of Virology. The four-page report by the Office of the Director of...

Part 2 of the Global Health Cast on Dengue presented by Prof. Schmitt and Dr. Leong. 00:00 Introduction 01:20 How is dengue virus transmitted to humans 01:52 Aedes aegypti 02:52 Different strains of dengue...

An EU-funded and WHO-implemented project helped health systems become more resilient and better prepared to tackle future epidemics of vaccine-preventable diseases. COVID-19 vaccination coverage is on the rise...

Part 1 of the Global Health Cast on Dengue presented by Prof. Schmitt and Prof. Sáfadi. 00:00 Introduction 01:07 Global risk of dengue 06:02 Arboviral diseases in the Americas Region 08:32 Dengue Virus 09:46...

Researchers from The University of Queensland have made a dust from baker’s yeast that can detect COVID-19 and could safeguard communities against future pandemics. The powdery ‘nanoprobes’ developed at UQ’s...

Critical insights into why airborne viruses lose their infectivity have been uncovered by scientists at the University of Bristol. The findings, published in the Journal of the Royal Society Interface, reveal...

Scientists in the UK have warned about a new ‘deadly virus’ which is ‘highly likely’ to arrive due to climate change. The UK government’s Science, Innovation and Technology Committee was informed of the...

Malaria infection in humans, caused by unicellular parasites from the genus Plasmodium and transmitted via the bite of an infected Anopheles mosquito, is a major global health challenge. Researchers are...

Infectious diseases and respiratory infections in particular are a leading cause of global mortality. As such, there is an urgent need for rapid, large-scale diagnostic tools that can detect these diseases...

The Bill & Melinda Gates Foundation  announced a renewed collaboration with the Beijing Municipal Government and Tsinghua University to support the Global Health Drug Discovery Institute (GHDDI) in its...

New analysis shows how the SARS-CoV-2 virus spreads from the nose to the air and surfaces in the immediate surroundings. The findings are the second batch of results to come from the COVID-19 Human Challenge...

No serious side effects were found in children aged 5 years or younger who were given mRNA COVID-19 vaccines, according to a recent study published in Pediatrics. Researchers of the study examined the patient...

In recent years, we’ve witnessed some truly inspiring progress in vaccine development. That includes the mRNA vaccines that were so critical during the COVID-19 pandemic, the first approved vaccine for...

Why is the SARS-CoV-2 coronavirus able to spread so efficiently? Various hypotheses are still circulating in the scientific community. A group of researchers from Würzburg has now found groundbreaking answers...

Fortieth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:31 COVID-19, depressive, cognitive symptoms, brain inflammation 03:26 Cats transmit COVID-19 to each...

Sixth SPECIAL Edition on The European Health Data Space of the Global Health Cast presented by Prof. Schmitt and Prof. Dipak Kalra.
Download PDF: Video Presentation
Click here for more Global Health Casts: 

Scientists from Cologne criticize the severely limited availability of flucytosine, which requires urgent action by authorities and the pharmaceutical industry. Under the leadership of Professor Dr Oliver A...

Thirty-ninth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:19 RSV-trials –overview 04:04 Pre-infection COVID vaccination linked to lower Long COVID odds...

Duke Health is leading its first clinical trial under a large federal initiative to develop a new-generation flu vaccine. The phase 1 clinical trial, which launched last month, is testing the safety of a...

Every year, hundreds of thousands of people in West Africa become infected with Lassa virus, which can cause Lassa fever and lead to severe illness, long-term side effects or death. There are currently no...

Researchers have called for pilot manufacturing facilities to be constructed ‘at-risk’, to ensure this game-changing technology is ready for deployment before the next pandemic. Needle-free vaccines could...

The World Health Organization (WHO) launched the International Pathogen Surveillance Network (IPSN), a public health network to prevent and detect infectious disease threats before they become epidemics or...

Thirty-eighth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:04 What to expect with the end of PHE for COVID 05:05 SARS-CoV-2 at the Huanan Seafood Market...

Infectious disease outbreaks in African countries are, unfortunately, all too common. Ebola in the Democratic Republic of the Congo or Uganda; Marburg virus in Guinea or Equatorial Guinea; cholera in Malawi;...

Thirty-seventh Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:04 COVID-19 global health emergency is OVER 03:10 COVID-19 epidemiology 10:24 Obstructive...

The World Health Organization (WHO) ended the global emergency status for COVID-19 on 5 May, more than three years after its original declaration, and said countries should now manage the virus that killed...

In a research article published in Nature Biotechnology, a team from the Koch Institute for Integrative Cancer Research at MIT details their journey in devising an exciting new methodology for delivering...

In a study published in Nature Microbiology, Harvard researchers found evidence that viruses infecting microbes in the deep sea interact with a far more diverse set of hosts than previously thought. The...

When new COVID-19 vaccines were first administered two years ago, public health officials found an increase in cases of myocarditis, an inflammation of the heart muscle, particularly among young males who had...

ASU professor and team find that arsenite induces cell death and could lead to over inflammation Cells are the building blocks of our body and many other organisms. But did you know that sometimes cells need...

In the early days of the pandemic, there was hope that being infected once with the coronavirus would grant immunity against future infections. As we all know by now, that is not how things played out. Yet...

Thirty-sixth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:05 COVID-19 update including variants 06:36 Why infectious diseases will increase in the future...

Thirty-fifth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:58 COVID-19 update 08:03 RSVPreF OA: Efficacy and license 14:39 COVID19: Past and future of...

The impressive feat of detective work has revealed thousands of sequences that have never been seen before. DNA sequences from over 30,000 previously unknown viruses have been discovered, thanks to a seriously...

A massive US-based study involving tens of thousands of military veterans has concluded there is a negligible risk of developing a blood clot as a result of a COVID-19 vaccine. While the results might do...

Thirty-fourth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:59 COVID-19 update 05:28 MPOX 06:58 RSV-vaccine efficacy in adults 13:23 Crimean-Congo...

A study led by UB researchers has confirmed that, contrary to claims by anti-vaccine proponents, COVID-19 vaccines pose only trivial risk of venous thromboembolism (VTE), or blood clots. In addition, the study...

The burgeoning incidence of infectious diseases (IDs), especially with a surge in chronic infections, pandemic outbreaks, and possible emerging biothreats, pose a significant challenge to public health...

In a recent study posted to the Preprints with The Lancet / SSRN´s First Look* preprint server, researchers explored national surveillance for new diseases in different countries. Novel pathogen-induced...

The CDC and FDA have decided that one updated COVID booster is enough for now, in contrast to recommendations from other countries and global health organizations Many people in the U.S. who are fully...

Testing the efficacy of a vaccine candidate is typically a long process, with the immune response of an animal model taking around two months. A multi-institution team, led by Matt DeLisa, the William L. Lewis...

Thirty-third Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:07 COVID-19 update 05:02 SARS-CoV-2 Variants 08:50 Most infectious diseases the WHO has...

Antibodies are a crucial ingredient in preventing infection for a wide variety of viruses. Scientists are frequently looking for new antibodies that could help fight viral infections. One deadly virus, the...

COVID-19 remained deadlier than influenza this past season, although the difference in mortality shrunk compared with past years, according to a study comparing outcomes of patients hospitalized with the...

With the risk of mosquito-borne disease expected to grow with climate change, a new study by Stanford researchers and their Kenyan colleagues sheds light on the factors that put communities at risk for these...

Adjuvants—ingredients that help boost the immune response in vaccines—have been used in vaccines for decades. But inducing a stronger immune response can result in more unwanted side effects, like swelling at...

The saliva of mosquitoes infected with dengue viruses contains a substance that thwarts the human immune system and makes it easier for people to become infected with the potentially deadly viruses, new...

Thirty-second Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:12 COVID-19 update 07:18 Roadmap for COVID-19 vaccination in the Omicron era 15:14 Long COVID...

Researchers from TU/e, Fontys Hogescholen and Rijnstate Ziekenhuis have developed a new bioluminescence-based sensor that can detect tiny amounts of viral or bacterial DNA/RNA in samples. PCR testing – the...

Infectious diseases are a problem everywhere — but more so in the world’s poorer countries. Every year, malaria, HIV and tuberculosis (TB) kill over 2.8 million people, and more than 1.7 billion people require...

Thirty-first Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:55 COVID-19 update 03:08 Flu update 07:04 March 24 was World TB Day 11:13 Acute effects of...

In a trial led by Stanford Medicine researchers, more than half of patients with persistent smell loss saw improvement with injections of platelet-rich plasma. Early in the pandemic, when people with COVID-19...

Time heals many wounds. But not all of them. Three years ago, on March 11, 2020, the World Health Organization officially bestowed pandemic status on COVID-19. Now, much of the fear that accompanied that...

A recent study found that chatbot systems that used artificial intelligence (AI) could be valuable in providing access to current, accurate, and complete information about infectious diseases and vaccines...